| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8447505 | European Journal of Cancer | 2011 | 14 Pages |
Abstract
Bevacizumab is associated with a lower risk of anaemia and increased risks of neutropenia, thrombocytopenia and febrile neutropenia.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Fabio A.B. Schutz, Denis L.F. Jardim, Youjin Je, Toni K. Choueiri,